SCNI
Scinai Immunotherapeutics Ltd
NASDAQ: SCNI · HEALTHCARE · BIOTECHNOLOGY
$0.74
+3.67% today
Updated 2026-04-30
Market cap
$2.06M
P/E ratio
0.00
P/S ratio
1.58x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$0 – $3
Volume
4.1M
Scinai Immunotherapeutics Ltd (SCNI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-702.00%
ROE
-91.90%
ROA
-37.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $2.50M | — | 43.57% | — | — |
| 2007 | $1.37M | — | 29.11% | — | — |
| 2008 | — | $-1.21M | — | — | — |
| 2009 | — | $-1.17M | — | — | — |
| 2010 | — | $-2.49M | — | — | — |
| 2011 | — | $-2.16M | — | — | — |
| 2012 | — | $-2.43M | — | — | — |
| 2013 | — | $-2.32M | — | — | — |
| 2014 | — | $-1.99M | — | — | — |
| 2015 | — | $-2.62M | — | — | — |
| 2016 | — | $-2.38M | — | — | — |
| 2017 | — | $-9.93M | — | — | — |
| 2018 | — | $-23.46M | — | — | — |
| 2019 | $0.00 | $-31.62M | — | — | — |
| 2020 | $0.00 | $-1.39M | — | — | — |
| 2021 | $0.00 | $-8.21M | — | — | — |
| 2022 | $0.00 | $-5.80M | — | — | — |
| 2023 | $0.00 | $-6.50M | — | — | — |
| 2024 | $658000.00 | $4.80M | -88.15% | -1,312.77% | 728.88% |
| 2025 | $1.31M | $-8.31M | -202.29% | -575.29% | -633.64% |